Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Baxter International Inc.
  6. Summary
    BAX   US0718131099

BAXTER INTERNATIONAL INC.

(BAX)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
06/14/2021 06/15/2021 06/16/2021 06/17/2021 06/18/2021 Date
82.77(c) 81.95(c) 81.77(c) 81.15(c) 80.82(c) Last
2 994 508 2 286 273 1 911 197 2 668 295 4 294 287 Volume
+0.64% -0.99% -0.22% -0.76% -0.41% Change
More quotes
Financials (USD)
Sales 2021 12 657 M - -
Net income 2021 1 636 M - -
Net Debt 2021 2 243 M - -
P/E ratio 2021 26,6x
Yield 2021 1,27%
Sales 2022 13 307 M - -
Net income 2022 1 931 M - -
Net Debt 2022 1 916 M - -
P/E ratio 2022 21,5x
Yield 2022 1,40%
Capitalization 40 640 M 40 640 M -
EV / Sales 2021 3,39x
EV / Sales 2022 3,20x
Nbr of Employees 50 000
Free-Float 73,4%
More Financials
Company
Baxter International Inc., through its subsidiaries, provides renal and hospital products. The Company operates through two segments: Hospital Products and Renal. Its Hospital Products business manufactures sterile intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, parenteral nutrition... 
Read more
More about the company
Ratings of Baxter International Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B+
More Ratings
All news about BAXTER INTERNATIONAL INC.
06/16BAXTER INTERNATIONAL  : Finding Purpose Through Volunteerism
PU
06/16BAXTER INTERNATIONAL  : to Host Second-Quarter 2021 Financial Results Conference..
AQ
06/15BAXTER INTERNATIONAL  : to Host Second-Quarter 2021 Financial Results Conference..
BU
06/08BAXTER INTERNATIONAL  : Presents Data at 58th ERA-EDTA Congress Indicating Thera..
BU
06/03BAXTER INTERNATIONAL INC. : Ex-dividend day for
FA
06/02BAXTER INTERNATIONAL  : Launches the Sharesource Analytics 1.0 Digital Health Mo..
BU
05/25BAXTER INTERNATIONAL  : Barclays Starts Baxter International at Equalweight with..
MT
05/25BAXTER INTERNATIONAL  : Launches PrisMax 2 System to Advance Critical Care Deliv..
BU
05/11PRESS RELEASE : MIG portfolio company AMSilk completes EUR29 million financing r..
DJ
05/05BAXTER INTERNATIONAL INC  : Submission of Matters to a Vote of Security Holders ..
AQ
05/04BAXTER INTERNATIONAL  : to Present at the UBS Global Healthcare Virtual Conferen..
BU
05/04BAXTER INTERNATIONAL  : Ups Dividend by 14% to $0.28/Share, Payable on July 1 to..
MT
05/04BAXTER INTERNATIONAL  : Board Boosts Quarterly Dividend By 14%
MT
05/03Baxter International Raises Dividend 14%
DJ
05/03BAXTER INTERNATIONAL  : Increases Dividend and Declares Quarterly Dividend
BU
More news
News in other languages on BAXTER INTERNATIONAL INC.
04/27DGAP-NEWS : MIG AG verzeichnet 2020 bestes Jahr der Unternehmensgeschichte und s..
03/15HINTERGRUND/Biontech formt globale Allianz für mehr Corona-Impfstoff
03/08MODERNA  : Baxter International va aider à fabriquer le vaccin
02/23Farmacéuticas rivales se unen para fabricar más vacunas de Covid-19
2020EN DIRECT DES MARCHES  : Sanofi, Dassault, Ubisoft, Softbank, Vale, Tesla, Signi..
More news
Analyst Recommendations on BAXTER INTERNATIONAL INC.
More recommendations
Analysis
One of the few top U.S. Black CEOs, Merck's Ken Frazier to retire
Chart BAXTER INTERNATIONAL INC.
Duration : Period :
Baxter International Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BAXTER INTERNATIONAL INC.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Average target price 93,59 $
Last Close Price 80,82 $
Spread / Highest target 29,9%
Spread / Average Target 15,8%
Spread / Lowest Target -1,01%
EPS Revisions
Managers and Directors
NameTitle
José E. Almeida Chairman, President & Chief Executive Officer
James K. Saccaro Chief Financial Officer & Executive Vice President
Sumant Ramachandra Senior VP, Chief Science & Technology Officer
Tobi Karchmer Vice President-Worldwide Medical
Talvis Love Chief Information Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
BAXTER INTERNATIONAL INC.0.72%40 640
ABBOTT LABORATORIES0.77%196 037
MEDTRONIC PLC5.20%165 794
BECTON, DICKINSON AND COMPANY-3.87%69 953
HOYA CORPORATION1.26%48 451
ALIGN TECHNOLOGY, INC.12.59%47 612